DCM Shriram subsidiary Bioseed Research USA liquidated
DCM Shriram Consolidated announced the liquidation of its wholly-owned step-down subsidiary, Bioseed Research USA Inc., effective December 15, 2025. The subsidiary had no turnover and a net worth of USD 3,271.00 as of March 31, 2025. The voluntary liquidation was disclosed to stock exchanges on December 19, 2025, in compliance with SEBI regulations. This move appears to streamline DCM Shriram's international subsidiary structure.

*this image is generated using AI for illustrative purposes only.
DCM Shriram Consolidated has announced the liquidation of its wholly-owned step-down subsidiary, Bioseed Research USA Inc., effective December 15, 2025. The company disclosed this development to the stock exchanges on December 19, 2025, in compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
Subsidiary Liquidation Details
The liquidation became effective from December 15, 2025, following which Bioseed Research USA Inc. ceased to be a wholly-owned subsidiary of DCM Shriram Consolidated. The company received intimation of the liquidation on December 19, 2025, at approximately 4:00 a.m. IST.
| Parameter | Details |
|---|---|
| Effective Date | December 15, 2025 |
| Intimation Received | December 19, 2025 |
| Type of Liquidation | Voluntary |
| Subsidiary Status | Wholly-owned step-down subsidiary |
Financial Position
As of March 31, 2025, Bioseed Research USA Inc. maintained a minimal financial footprint with the following position:
| Financial Metric | Amount |
|---|---|
| Turnover | Nil |
| Net Worth | USD 3,271.00 |
The subsidiary had no revenue or income contribution to DCM Shriram Consolidated during the last financial year, indicating limited operational activities.
Regulatory Compliance
The disclosure was made pursuant to Regulation 30 read with Para A of Schedule III of SEBI Listing Regulations, 2015. The company also referenced compliance with SEBI Master Circular No. SEBI/HO/CFD/PoD-2/CIR/P/0155 dated November 11, 2024.
Key regulatory aspects include:
- No sale agreement involved as the entity was voluntarily liquidated
- No buyer details applicable due to voluntary liquidation
- No related party transactions involved in the process
- Liquidation subject to necessary tax and accounting filings under local US laws
Corporate Structure Impact
With the liquidation of Bioseed Research USA Inc., DCM Shriram Consolidated's international subsidiary structure has been streamlined. The voluntary nature of the liquidation suggests a strategic decision to optimize the corporate structure and reduce administrative overhead for a non-operational entity.
The liquidation process remains subject to completion of necessary tax and accounting filings by Bioseed Research USA Inc. in accordance with local US laws and regulations.
Historical Stock Returns for DCM Shriram Consolidated
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.39% | -2.59% | +2.94% | +3.76% | +11.98% | +209.59% |
















































